BioScience Health Innovations (BHIC) Return on Sales (2023 - 2026)

BioScience Health Innovations (BHIC) has 4 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.0%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales advanced to 0.0% in Q1 2026 per BHIC's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q1 2025 and troughed at 0.02% in Q1 2023.
• A 4-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2024 and 2026: Return on Sales rose 2 bps in 2024, then decreased 1 bps in 2026.
• A 4-year view of Return on Sales shows it stood at 0.0% in 2023, then soared by 31 bps to 0.0% in 2024, then plunged by 404 bps to 0.0% in 2025, then increased by 30 bps to 0.0% in 2026.
• Business Quant data shows BHIC's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.